• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有微量白蛋白尿的II型糖尿病患者尿纤连蛋白排泄增加。

Increased urinary fibronectin excretion in type II diabetic patients with microalbuminuria.

作者信息

Takahashi M

机构信息

Third Department of Internal Medicine, Fukushima Medical College, Japan.

出版信息

Nihon Jinzo Gakkai Shi. 1995 Jun;37(6):336-42.

PMID:7666599
Abstract

A series of recent observations have shown raised levels of plasma fibronectin (FN), an alpha 2-glycoprotein produced by vascular endothelia, in diabetic patients with retinopathy and overt nephropathy. However, there are no available data on urinary FN and behavior of its excretion in patients affected by diabetic nephropathy characterized by the presence of microalbuminuria. The main purpose of the present study was to investigate whether the urinary excretion of FN (U-FN) is associated with early diabetic nephropathy and other diabetic complications. Fifty-nine diabetic inpatients classified as type II and 15 age-matched control subjects were included in this study. The amount of U-FN, assessed as microgram/g creatinine/24 h, was significantly greater in the patients as a group (348.1 +/- 48.3), than in the controls (108.6 +/- 22.7, p < 0.01). Although patients with overt proteinuria showed an extremely high level of U-FN (1080.5 +/- 184.0; range 216.1 +/- 1726.8), mean U-FN tended to be higher in the group with microalbuminuria (262.4 +/- 21.9; range 101.9-591.9) than in the group without it (188.1 +/- 34.3; range 19.4 +/- 582.4, p < 0.08). In patients who did not have retinopathy and neuropathy, the U-FN was significantly higher in the group with microalbuminuria (222.5 +/- 28.5) than in the group without it (116.1 +/- 22.6, p < 0.01). A highly significant negative correlation existed between endogenous creatinine clearance values and the amounts of U-FN in the patients (r = -0.642, p < 0.01), while there was no such relationship in the controls (r = 0.167, p = NS).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

最近一系列观察结果显示,在患有视网膜病变和显性肾病的糖尿病患者中,血浆纤连蛋白(FN,一种由血管内皮产生的α2 - 糖蛋白)水平升高。然而,关于糖尿病肾病伴有微量白蛋白尿患者的尿FN及其排泄行为,尚无可用数据。本研究的主要目的是调查尿FN排泄量(U - FN)是否与早期糖尿病肾病及其他糖尿病并发症相关。本研究纳入了59例II型糖尿病住院患者和15例年龄匹配的对照受试者。以微克/克肌酐/24小时评估的U - FN量,患者组(348.1±48.3)显著高于对照组(108.6±22.7,p < 0.01)。虽然显性蛋白尿患者的U - FN水平极高(1080.5±184.0;范围216.1±1726.8),但微量白蛋白尿组的平均U - FN(262.4±21.9;范围101.9 - 591.9)倾向于高于无微量白蛋白尿组(188.1±34.3;范围19.4±582.4,p < 0.08)。在没有视网膜病变和神经病变的患者中,微量白蛋白尿组的U - FN(222.5±28.5)显著高于无微量白蛋白尿组(116.1±22.6,p < 0.01)。患者的内生肌酐清除率值与U - FN量之间存在高度显著的负相关(r = -0.642,p < 0.01),而对照组中不存在这种关系(r = 0.167,p =无显著性差异)。(摘要截短至250字)

相似文献

1
Increased urinary fibronectin excretion in type II diabetic patients with microalbuminuria.伴有微量白蛋白尿的II型糖尿病患者尿纤连蛋白排泄增加。
Nihon Jinzo Gakkai Shi. 1995 Jun;37(6):336-42.
2
Diagnostic significance of urinary fibronectin in diabetic nephropathy.尿纤连蛋白在糖尿病肾病中的诊断意义
Nihon Jinzo Gakkai Shi. 1995 Feb;37(2):127-33.
3
Effects of aerobic exercise on microalbuminuria and enzymuria in type 2 diabetic patients.有氧运动对2型糖尿病患者微量白蛋白尿和酶尿的影响。
Ren Fail. 2007;29(2):199-205. doi: 10.1080/08860220601098870.
4
Clinical significance and different levels of urinary monocyte chemoattractant protein-1 in type 2 diabetes mellitus.2型糖尿病患者尿单核细胞趋化蛋白-1的临床意义及不同水平
Diabetes Res Clin Pract. 2009 Feb;83(2):215-9. doi: 10.1016/j.diabres.2008.09.048. Epub 2008 Dec 20.
5
Urinary concentration of transforming growth factor-beta-inducible gene-h3(beta ig-h3) in patients with Type 2 diabetes mellitus.2型糖尿病患者尿液中转化生长因子β诱导基因h3(βig-h3)的浓度
Diabet Med. 2005 Jan;22(1):14-20. doi: 10.1111/j.1464-5491.2004.01295.x.
6
Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?血浆同型半胱氨酸与糖尿病患者的白蛋白排泄率相关:糖尿病肾病与心血管疾病之间的新联系?
Diabetologia. 1998 Jun;41(6):684-93. doi: 10.1007/s001250050969.
7
[Microalbuminuria in diabetics with moderate hypertension].[中度高血压糖尿病患者的微量白蛋白尿]
Arch Mal Coeur Vaiss. 1986 Jun;79(6):785-9.
8
Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.2型糖尿病患者血浆及尿液血管内皮生长因子与糖尿病肾病
Diabet Med. 2004 Jun;21(6):545-51. doi: 10.1111/j.1464-5491.2004.01200.x.
9
Microalbuminuria in non-insulin-dependent diabetes.非胰岛素依赖型糖尿病中的微量白蛋白尿
Clin Nephrol. 1992;38 Suppl 1:S28-39.
10
Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.2型糖尿病中触珠蛋白表型与糖尿病肾病标志物的关联
J Diabetes Complications. 2008 Nov-Dec;22(6):384-8. doi: 10.1016/j.jdiacomp.2007.07.004. Epub 2008 Apr 16.

引用本文的文献

1
Changes in Urinary NGAL, FN, and LN Excretion in Type 2 Diabetic Patients Following Anti-Diabetic Therapy with Metformin.2型糖尿病患者接受二甲双胍抗糖尿病治疗后尿中性粒细胞明胶酶相关脂质运载蛋白、纤连蛋白和层粘连蛋白排泄量的变化
J Clin Med. 2025 Feb 8;14(4):1088. doi: 10.3390/jcm14041088.
2
Novel biomarkers for prognosticating diabetic kidney disease progression.用于预测糖尿病肾病进展的新型生物标志物。
Int Urol Nephrol. 2023 Apr;55(4):913-928. doi: 10.1007/s11255-022-03354-7. Epub 2022 Oct 22.
3
The role of novel biomarkers in predicting diabetic nephropathy: a review.
新型生物标志物在预测糖尿病肾病中的作用:综述
Int J Nephrol Renovasc Dis. 2017 Aug 17;10:221-231. doi: 10.2147/IJNRD.S143186. eCollection 2017.
4
Effects of anesthetics pentobarbital sodium and chloral hydrate on urine proteome.麻醉剂戊巴比妥钠和水合氯醛对尿液蛋白质组的影响。
PeerJ. 2015 Mar 12;3:e813. doi: 10.7717/peerj.813. eCollection 2015.
5
Therapeutic targets for treating fibrotic kidney diseases.治疗纤维化肾病的治疗靶点。
Transl Res. 2015 Apr;165(4):512-30. doi: 10.1016/j.trsl.2014.07.010. Epub 2014 Aug 13.
6
Urinary biomarkers for early diabetic nephropathy: beyond albuminuria.早期糖尿病肾病的尿液生物标志物:超越蛋白尿
Pediatr Nephrol. 2015 Jul;30(7):1063-75. doi: 10.1007/s00467-014-2888-2. Epub 2014 Jul 25.
7
Urinary markers of glomerular injury in diabetic nephropathy.糖尿病肾病中肾小球损伤的尿液标志物
Int J Nephrol. 2012;2012:146987. doi: 10.1155/2012/146987. Epub 2012 May 8.
8
Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers.糖尿病并发症中的纤维化:致病机制以及循环和尿液标志物
Vasc Health Risk Manag. 2008;4(3):575-96. doi: 10.2147/vhrm.s1991.